Amylyx Pharmaceuticals

AMLX

Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis. AMX0035 was approved for medical use in Canada as Albrioza, in June 2022, and in the United States, as Re …

Insider trades and stock quote 2023-2025

All insider trades at Amylyx Pharmaceuticals

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
3/31/2025 SellKlee, Justin B. Co-Chief Executive Officer $3.5 $74,454
3/31/2025 SellCohen, Joshua B. Co-Chief Executive Officer $3.5 $74,482
3/31/2025 SellMazzariello, Gina Chief Legal Officer $3.5 $31,954
3/31/2025 SellBedrosian, Camille L. Chief Medical Officer $3.5 $43,082
3/31/2025 SellFrates, James M. Chief Financial Officer $3.5 $37,806
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)